Semaglutide and Tirzepatide are advanced, once-weekly injectable medications that support weight loss by regulating appetite, blood sugar, and metabolism.

Semaglutide works on one hormone (GLP-1) to control appetite, while Tirzepatide targets two (GLP-1 and GIP), often leading to enhanced weight loss results for some patients.

Patients can lose an average of 10–25% of their body weight over time, depending on the medication, dosage, and lifestyle habits.

Both Semaglutide and Tirzepatide are administered once weekly. Many patients choose convenient at-home self-injections after guidance.

Yes. For optimal, long-term results, these treatments should be combined with a healthy diet and regular physical activity. We provide personalized guidance.